Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medios AGMEDOF 88 3-Year Book Growth Rate is 3.70% as of Jun. 2026, which is 90% below its 10-year median of 38.40. GuruFocus rates MEDOF with a GF Score™ of 88/100 and a GF Value™ of $79.50. The stock has 2 warning signs investors should review. Among 117 Medical Distribution companies, Medios AG ranks worse than 51.28% on this metric.
During the past 3 years, the average Book Value per Share Growth Rate was 3.70% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 14.70% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 32.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Medios AG was 414.40% per year. The lowest was -54.40% per year. And the median was 38.40% per year.
Medios AG (OTCPK:MEDOF) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Medios AG 3-Year Book Growth Rate Related Terms
MEDOF vs MCK, COR, CAH: 3-Year Book Growth Rate Comparison
For the Medical Distribution subindustry, Medios AG's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medios AG 3-Year Book Growth Rate vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medios AG's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Medios AG's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 3.70% mean?
Medios AG (MEDOF) has a 3-Year Book Growth Rate of 3.70% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Medios AG and its competitors. This is 90% below median its historical median of 38.40. According to the industry distribution chart, Medios AG ranks #60 out of 117 companies in the Medical Distribution industry, placing it in the top 51.3%.
Is Medios AG's 3-Year Book Growth Rate too high?
Medios AG's current 3-Year Book Growth Rate of 3.70% is 90% below median its 10-year median of 38.40. The Medical Distribution industry median 3-Year Book Growth Rate is 3.90. Medios AG's value of 3.70% is 5.1% below this industry median. Based on the distribution chart, Medios AG ranks #60 out of 117 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Medios AG has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Medios AG's 3-Year Book Growth Rate compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medios AG ranks #60 out of 117 companies for 3-Year Book Growth Rate. This places Medios AG in the lower half of its industry. The industry median 3-Year Book Growth Rate is 3.90. Medios AG's value of 3.70% is 5.1% below this benchmark. While the company's 10-year median is 38.40 vs. the industry median of 3.90, Medios AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Medical Distribution company?
The median 3-Year Book Growth Rate among Medical Distribution companies is 3.90, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medios AG's current 3-Year Book Growth Rate of 3.70% is 5.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Medios AG and its competitors. For the Medical Distribution industry, the median 3-Year Book Growth Rate is 3.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medios AG's current 3-Year Book Growth Rate is 3.70%, which is 90% below median its own 10-year median of 38.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medios AG stock overvalued right now?
Medios AG (MEDOF) has a current 3-Year Book Growth Rate of 3.70%. The stock's GF Value™ is $79.50, compared to a current price of $50.00 — trading 37.1% below its estimated fair value. The current 3-Year Book Growth Rate is 3.70%, which is 90% below median its 10-year median of 38.40 and 5.1% below the Medical Distribution industry median of 3.90. Medios AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Medios AG (MEDOF), the current 3-Year Book Growth Rate is 3.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medios AG (MEDOF) Overvalued in 2026?
Based on GuruFocus' analysis, Medios AG stock appears to be undervalued.
The current stock price of $50.00 is trading 37.1% below its estimated GF Value™ of $79.50.
Key valuation signals for MEDOF:
3-Year Book Growth Rate: 3.70% (90% below median its 10-year median of 38.40)
GF Value™: $79.50 vs. price of $50.00 (37.1% below fair value)
Industry Position: 5.1% below the Medical Distribution median (#60 of 117)
No single metric tells the full story. See the MEDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score
Get the complete analysis for MEDOF
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEDOF has been successfully added to your 
